Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.35 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13485270 | 0.81 | CYP1A2 (0.43) | KDM4EALDH1A1GAALMNAHTT | |
| SCHEMBL7770916 | 0.77 | HTR1A (0.38) | KDM4EALDH1A1LMNA | |
| SCHEMBL11268376 | 0.73 | ALDH1A1 (0.42) | KDM4EALDH1A1GAALMNA | |
| SCHEMBL1175741 | 0.71 | AADAT (0.30) | — | |
| SCHEMBL16925898 | 0.70 | ALDH1A1 (0.33) | KDM4EALDH1A1GAALMNA | |
| SCHEMBL8255873 | 0.69 | GAA (0.33) | GAA | |
| SCHEMBL8180905 | 0.67 | KDM4E (0.35) | KDM4EALDH1A1GAALMNAHTT | |
| SCHEMBL5413587 | 0.67 | KDM4E (0.43) | KDM4EALDH1A1GAALMNAHTT | |
| SCHEMBL3825323 | 0.67 | KDM4E (0.43) | KDM4EALDH1A1GAALMNAHTT | |
| SCHEMBL5344420 | 0.67 | KDM4E (0.43) | KDM4EALDH1A1GAALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0854860-B1 | A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME | CIE DE DEV AGUETTANT (FR) | 2001-07-25 | — | — | EP | claimed |
| EP-0854860-A1 | A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME | COMPAGNIE DE DEVELOPPEMENT AGUETTANT (FR) | 1998-07-29 | — | — | EP | claimed |
| US-5705522-A | D-ACETAMIDO-N-HYDROXY SUCCINAMIC ACID DERIVATIVES; AIDS, HIV INFECTIONS | COMPAGNIE DE DEVELOPPEMENT AGUETTANT S.A. (FR) | 1998-01-06 | — | — | US | claimed |
| WO-1997010205-A1 | A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME | COMPAGNIE DE DEVELOPPEMENT AGUETTANT (FR) | 1997-03-20 | — | — | WO | claimed |
| EP-0854860-B1 | A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME | CIE DE DEV AGUETTANT (FR) | 2001-07-25 | — | — | EP | disclosed |
| EP-0854860-A1 | A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME | COMPAGNIE DE DEVELOPPEMENT AGUETTANT (FR) | 1998-07-29 | — | — | EP | disclosed |
| US-5705522-A | D-ACETAMIDO-N-HYDROXY SUCCINAMIC ACID DERIVATIVES; AIDS, HIV INFECTIONS | COMPAGNIE DE DEVELOPPEMENT AGUETTANT S.A. (FR) | 1998-01-06 | — | — | US | disclosed |
| WO-1997010205-A1 | A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME | COMPAGNIE DE DEVELOPPEMENT AGUETTANT (FR) | 1997-03-20 | — | — | WO | disclosed |